Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Nature|November 7, 2018
Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeysErica N Borducchi, Jinyan Liu, Joseph P Nkolola, et al.Journal of Virology|April 13, 2018
Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea PigsChristine A Bricault, James M Kovacs, Alexander Badamchi-Zadeh, et al.Nature|October 5, 2018
Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeysErica N Borducchi, Jinyan Liu, Joseph P Nkolola, et al.Science Translational Medicine|September 22, 2017
Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktailBoris Julg, Po-Ting Liu, Kshitij Wagh, et al.Nature Communications|June 17, 2022
Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaquesVictoria E K Walker-Sperling, Noe B Mercado, Abishek Chandrashekar, et al.Nature Communications|March 6, 2021
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus MacaquesAnthony M Cadena, John D Ventura, Peter Abbink, et al.Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.NPJ Vaccines|May 18, 2022
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaquesJohn D Ventura, Joseph P Nkolola, Abishek Chandrashekar, et al.Nature|November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysDan H Barouch, James B Whitney, Brian Moldt, et al.Nature Medicine|September 12, 2024
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trialBoris Julg, Victoria E K Walker-Sperling, Kshitij Wagh, et al.Pageof 5